{"id":"https://openalex.org/W2901471644","doi":"https://doi.org/10.1371/journal.pone.0207224","title":"Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer","display_name":"Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer","publication_year":2018,"publication_date":"2018-11-14","ids":{"openalex":"https://openalex.org/W2901471644","doi":"https://doi.org/10.1371/journal.pone.0207224","mag":"2901471644","pmid":"https://pubmed.ncbi.nlm.nih.gov/30427884","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6235359"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0207224","doi":"https://doi.org/10.1371/journal.pone.0207224","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0207224","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0207224&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0207224&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070148791","display_name":"Javier Cuello L\u00f3pez","orcid":"https://orcid.org/0000-0001-9741-5322","observed_orcids":["https://orcid.org/0000-0001-9741-5322"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Javier Cuello-L\u00f3pez","raw_affiliation_strings":["Clinical Oncology Group, Fundaci\u00f3n Colombiana de Cancerolog\u00eda-Cl\u00ednica Vida, Medell\u00edn, Colombia"],"raw_orcid":"https://orcid.org/0000-0001-9741-5322","affiliations":[{"raw_affiliation_string":"Clinical Oncology Group, Fundaci\u00f3n Colombiana de Cancerolog\u00eda-Cl\u00ednica Vida, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042694355","display_name":"Ana Fidalgo Zapata","orcid":"https://orcid.org/0000-0001-6607-0114","observed_orcids":["https://orcid.org/0000-0001-6607-0114"]},"institutions":[{"id":"https://openalex.org/I4210128920","display_name":"Universidad CES","ror":"https://ror.org/037p13h95","country_code":"CO","type":"education","lineage":["https://openalex.org/I4210128920"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Ana Fidalgo-Zapata","raw_affiliation_strings":["Breast Surgeon Fellowship Program, School of Medicine, CES University, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Surgeon Fellowship Program, School of Medicine, CES University, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I4210128920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026068469","display_name":"L.D. L\u00f3pez Agudelo","orcid":"https://orcid.org/0000-0001-5274-5299","observed_orcids":["https://orcid.org/0000-0001-5274-5299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura L\u00f3pez-Agudelo","raw_affiliation_strings":["Fundaci\u00f3n Colombiana de Cancerolog\u00eda-Cl\u00ednica Vida, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Colombiana de Cancerolog\u00eda-Cl\u00ednica Vida, Medell\u00edn, Colombia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082937761","display_name":"Elsa Mar\u00eda V\u00e1squez Trespalacios","orcid":"https://orcid.org/0000-0002-0665-5310","observed_orcids":["https://orcid.org/0000-0002-0665-5310"]},"institutions":[{"id":"https://openalex.org/I4210128920","display_name":"Universidad CES","ror":"https://ror.org/037p13h95","country_code":"CO","type":"education","lineage":["https://openalex.org/I4210128920"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Elsa V\u00e1squez-Trespalacios","raw_affiliation_strings":["Department of Clinical Epidemiology, School of Medicine, CES University, Medell\u00edn, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Epidemiology, School of Medicine, CES University, Medell\u00edn, Colombia","institution_ids":["https://openalex.org/I4210128920"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070148791"],"corresponding_institution_ids":[],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.2357,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.94857986,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"13","issue":"11","first_page":"e0207224","last_page":"e0207224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-to-lymphocyte-ratio","display_name":"platelet-to-lymphocyte ratio","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.8989999890327454},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.8230000138282776},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8679999709129333},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.871999979019165},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7540000081062317},{"id":"https://openalex.org/keywords/her2-enriched-breast-cancer","display_name":"HER2-enriched breast cancer","score":0.8629999756813049},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9240000247955322},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.6899999976158142},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9120000004768372}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.682114839553833},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6659655570983887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6630522012710571},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.533923864364624},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.5045570135116577},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.5011060237884521},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44881102442741394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4340294897556305},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4118342101573944},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4040648639202118},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3477917015552521}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003105","descriptor_name":"Colombia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1371/journal.pone.0207224","doi":"https://doi.org/10.1371/journal.pone.0207224","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0207224","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0207224&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5237531","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6235359","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6235359","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6235359","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:30427884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30427884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:3848ddcfcd134e53a23945f9a6894ab6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3848ddcfcd134e53a23945f9a6894ab6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 13, Iss 11, p e0207224 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0207224","doi":"https://doi.org/10.1371/journal.pone.0207224","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0207224","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0207224&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2901471644.pdf","grobid_xml":"https://content.openalex.org/works/W2901471644.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1586470106","https://openalex.org/W1841839849","https://openalex.org/W1956784352","https://openalex.org/W1982453726","https://openalex.org/W1986632581","https://openalex.org/W1993702531","https://openalex.org/W1993896523","https://openalex.org/W2006070721","https://openalex.org/W2009098155","https://openalex.org/W2016722329","https://openalex.org/W2020684281","https://openalex.org/W2067971776","https://openalex.org/W2075894019","https://openalex.org/W2088574179","https://openalex.org/W2096145980","https://openalex.org/W2099005045","https://openalex.org/W2113187757","https://openalex.org/W2117083748","https://openalex.org/W2117692326","https://openalex.org/W2117775530","https://openalex.org/W2119549339","https://openalex.org/W2120431466","https://openalex.org/W2125885282","https://openalex.org/W2133569215","https://openalex.org/W2147415463","https://openalex.org/W2154142993","https://openalex.org/W2168064072","https://openalex.org/W2168299243","https://openalex.org/W2169945437","https://openalex.org/W2221588520","https://openalex.org/W2340735966","https://openalex.org/W2419617026","https://openalex.org/W2420462095","https://openalex.org/W2487595537","https://openalex.org/W2527994266","https://openalex.org/W2528841985","https://openalex.org/W2557243782","https://openalex.org/W2588033292","https://openalex.org/W2593789165"],"related_works":["https://openalex.org/W3157084026","https://openalex.org/W4284973925","https://openalex.org/W4387017686","https://openalex.org/W4401449857","https://openalex.org/W4303453967","https://openalex.org/W2907932706","https://openalex.org/W2588033292","https://openalex.org/W4324141659","https://openalex.org/W3180763887","https://openalex.org/W2487595537"],"abstract_inverted_index":{"Response":[0],"to":[1,27,39],"neoadjuvant":[2,40,62,97,239],"chemotherapy":[3,240],"in":[4,12,47,59,65,85,106,121,191],"breast":[5,89,228],"cancer":[6,229],"patients":[7,49,60,86,103,230],"is":[8],"of":[9,37,53,101,113,123,247],"prognostic":[10],"value":[11],"determining":[13],"short-":[14],"and":[15,25,73,80,94,126,156],"mid-term":[16],"outcomes.":[17],"Inflammatory":[18],"biomarkers,":[19],"such":[20],"as":[21,34,56],"platelet-to-lymphocyte":[22,233],"ratio":[23,29,234],"(PLR)":[24],"neutrophil":[26],"lymphocyte":[28],"(NLR),":[30],"have":[31],"been":[32],"proposed":[33],"predictive":[35],"factors":[36],"response":[38,57,187],"chemotherapy.":[41,63,98],"Currently,":[42],"there":[43],"are":[44],"no":[45],"studies":[46],"Colombian":[48],"reporting":[50],"the":[51,75,107,124,135,192,199,214],"role":[52],"inflammatory":[54,78],"biomarkers":[55,79],"predictors":[58],"receiving":[61],"Therefore,":[64],"this":[66],"study":[67,72],"we":[68],"performed":[69],"a":[70,110],"cross-sectional":[71],"analyzed":[74],"association":[76],"between":[77],"pCR":[81,216],"(pathological":[82],"complete":[83,185,243],"response)":[84],"diagnosed":[87],"with":[88,96,109,164,198,231,238],"cancer-of":[90],"different":[91],"molecular":[92,139,250],"subtypes-":[93],"treated":[95,237],"A":[99,158],"total":[100],"288":[102],"were":[104],"included":[105],"study,":[108],"median":[111],"age":[112],"51":[114],"years":[115],"old.":[116],"Disease":[117],"was":[118,141,161,188],"locally":[119],"advanced":[120],"83%":[122],"participants,":[125],"77.7%":[127],"had":[128],"compromised":[129],"lymph":[130,174],"nodes.":[131],"In":[132,209],"our":[133],"cohort,":[134],"most":[136],"frequent":[137],"tumor":[138,169,249],"subtype":[140],"luminal":[142,151,157],"B/Her2-":[143],"(27.8%)":[144],"followed":[145,219],"by":[146,220],"triple":[147],"negative":[148],"[TN]":[149],"(21.5%),":[150],"B/Her2+":[152],"(19.8%),":[153],"Her2-enriched":[154,211],"(16%)":[155],"(13.5%).":[159],"PLR":[160,194,201],"not":[162],"associated":[163],"age,":[165],"menopausal":[166],"status,":[167,181],"baseline":[168],"size,":[170],"histologic":[171],"grade,":[172],"axillary":[173],"node":[175],"involvement,":[176],"disease":[177],"stage,":[178],"estrogen":[179],"receptor":[180],"or":[182],"Ki67;":[183],"however,":[184],"pathological":[186,244],"significantly":[189],"higher":[190,242],"low":[193,232],"group":[195,202],"(PLR<150)":[196],"compared":[197],"high":[200],"(35.1%":[203],"Vs.":[204],"22.2%,":[205],"p":[206],"=":[207],"0.03).":[208],"addition,":[210],"tumors":[212],"achieved":[213],"highest":[215],"rates":[217],"(65%),":[218],"TN":[221],"(34%)":[222],"tumors.":[223],"Our":[224],"results":[225],"suggest":[226],"that":[227],"(PLR":[235],"<150),":[236],"achieve":[241],"response,":[245],"independently":[246],"primary":[248],"subtype.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-11-29T00:00:00"}